Even though discounted cards may help ease the burden of substantial drug fees while in the short term, they do not address the systemic issues driving up prescription rates inside the U.S. Broader policy adjustments could tackle the basis will cause of climbing drug selling prices, including insufficient transparency in pricing and the function of